featured
ASH 2021: Immune Checkpoint Inhibitor Use in Lung Cancer Linked With Risk of Venous Thromboembolism
Early identification and stratification of underlying risk factors are needed, to improve patient care
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.